ArboretumHome Page Midwest Growth Capital Symposium to Feature Crosslink Capital and Arboretum Ventures Keynotes for 2022 Organizers of the Midwest Growth Capital Symposium (MGCS) announced today that Michael Stark, Jan Garfinkle, and Tim Petersen will Keynote the…Arboretum_JDApril 8, 2022
Fifth EyeNews Page AirStrip® Adds Analytics Capabilities to Virtual Acute Care Platform via Partnership with Fifth Eye™ Fifth Eye™, a provider of intuitive real-time clinical analytics, announced today that it has entered…Arboretum_JDApril 5, 2022
EQRxNews Page EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…Arboretum_JDMarch 23, 2022
Home PageNews PageStrata Oncology Strata Oncology Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022 Strata Oncology, a precision oncology company advancing new molecular indications for cancer therapies, has been named…Arboretum_JDMarch 9, 2022
EQRxHome PageNews Page EQRx Debuts as Publicly Traded Company CM Life Sciences III (Nasdaq: CMLT, CMLTW, CMLTU), a life science-focused special purpose acquisition company,…Arboretum_JDDecember 17, 2021
Avation MedicalNews Page Avation Medical Announces the Appointment of Industry Veterans to Board of Directors Avation Medical, an innovative advanced neuromodulation and digital health company pioneering closed-loop, wearable neuromodulation therapies…Arboretum_JDDecember 9, 2021
Home PageNews PagePear Therapeutics Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Company Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription…Arboretum_JDDecember 6, 2021
EQRxNews Page EQRx and CM Life Sciences III Announce Stockholder Meeting Details to Vote on Proposed Business Combination EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…Arboretum_JDDecember 2, 2021
News PagePear Therapeutics Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics…Arboretum_JDNovember 23, 2021
EQRxNews Page Partnership Announcements for EQRx – Commercialization with Abdul Latif Jameel Health and Drug Discovery & Development with Evotech EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in…Arboretum_JDNovember 22, 2021